Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

160.05
+1.440.91%
Volume:1.38M
Turnover:221.08M
Market Cap:248.24B
PE:23.96
High:161.29
Open:159.07
Low:158.53
Close:158.61
52wk High:212.71
52wk Low:153.41
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.55
T/O Rate:0.09%
Dividend:3.17
Dividend Rate:1.98%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.21%
PB:4.94
PE(LYR):24.47

Loading ...

AstraZeneca's Research Engine is Still Humming

Dow Jones
·
Yesterday

Micro-Cap Stock Veraxa Biotech is Down 96% This Year. Can Next-Gen Drug Testing Save It?

Dow Jones
·
Yesterday

AstraZeneca (AZN) Receives a Buy from Berenberg Bank

TIPRANKS
·
Yesterday

Why Vaxcyte Chose A 1.5% Convertible

Macro World​
·
Yesterday

Bernstein Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Yesterday

AstraZeneca price target raised to 18,600 GBp from 17,800 GBp at Citi

TIPRANKS
·
Yesterday

AstraZeneca Advances Tuesday, Outperforms Market

Dow Jones
·
Yesterday

From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run

Bellwether Stocks Movement
·
Oct 06

Sector Update: Healthcare Stocks Rise Monday Afternoon

MT Newswires Live
·
Oct 06

AstraZeneca to Invest Over $1 Billion in Massachusetts

MT Newswires Live
·
Oct 06

AstraZeneca to Invest over $1 Billion in Massachusetts, Boost Workforce

Reuters
·
Oct 06

AstraZeneca opens R&D center in Cambridge, Massachusetts

TIPRANKS
·
Oct 06

AstraZeneca PLC Stock Falls Monday, Underperforms Market

Dow Jones
·
Oct 06

AstraZeneca completes $2B equity investment in Summit Therapeutics

TIPRANKS
·
Oct 05

One Molecule, Three Diseases, $1.55 Billion — Inside CSL's Bet

Bellwether Stocks Movement
·
Oct 05

Merck Doubled Off Its Lows — And Analysts Still See More Room

Bellwether Stocks Movement
·
Oct 05

Barclays Sticks to Their Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Oct 05

CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2

Bellwether Stocks Movement
·
Oct 05

Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs

Macro World​
·
Oct 03

23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook

Bellwether Stocks Movement
·
Oct 03